Discovery of novel 4-azaaryl-N-phenylpyrimidin-2-amine derivatives as potent and selective FLT3 inhibitors for acute myeloid leukaemia with FLT3 mutations
Long, Yi, Yu, Mingfeng, Ochnik, Aleksandra M., Karanjia, Jasmine D., Basnet, Sunita KC, Kebede, Alemwork A., Kou, Lianmeng, Wang, Shudong
Published in European journal of medicinal chemistry (05.03.2021)
Published in European journal of medicinal chemistry (05.03.2021)
Get full text
Journal Article
Abstract 5701: AU2-94: A CDK4-specific inhibitor with the marked anti-tumor efficacy
Bantie, Laychiluh, Likisa, Jimma, Rahaman, Muhammed, Teo, Theodosia, Safaroghliazar, Ava, Basnet, Sunita KC, Hassankhani, Ramin, Noll, Benjamin, Milne, Robert, Wang, Shudong
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Unveiling new chemical scaffolds as Mnk inhibitors
Diab, Sarah, Li, Peng, Basnet, Sunita K C, Lu, Jingfeng, Yu, Mingfeng, Albrecht, Hugo, Milne, Robert W, Wang, Shudong
Published in Future medicinal chemistry (01.01.2016)
Published in Future medicinal chemistry (01.01.2016)
Get full text
Journal Article
Discovery of N-phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine derivatives as potent Mnk2 inhibitors: design, synthesis, SAR analysis, and evaluation of in vitro anti-leukaemic activity
Abdelaziz, Ahmed M, Diab, Sarah, Islam, Saiful, Basnet, Sunita K C, Noll, Ben, Li, Peng, Mekonnen, Laychiluh B, Lu, Jingfeng, Albrecht, Hugo, Milne, Robert W, Gerber, Cobus, Yu, Mingfeng, Wang, Shudong
Published in Medicinal chemistry (Shp-sariqah, United Arab Emirates) (01.01.2019)
Published in Medicinal chemistry (Shp-sariqah, United Arab Emirates) (01.01.2019)
Get more information
Journal Article